Home The Word Brain	My Amedeo FAQ Privacy About
	Chinese Coaching Already know some Chinese? Stay on track with structured, one-on-one coaching to make steady, long-term progress. By Meng Wu and BSK.

Parkinson's Disease

Free Subscription 12.01.2026 1 Ann Neurol 2 BMC Neurol 1 BMC Neurosci 1 Brain Res 1 Exp Neurol 3 J Neural Transm (Vienna) 1 J Neurochem 4 Mov Disord 1 Neurochem Res 3 Neurology 5 PLoS One 2 Proc Natl Acad Sci U S A 1 Rev Neurol

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Ann Neurol

1. HAJJI-LOUATI M, Correia E, Lee PC, Artaud F, et al
   Adherence to the Mediterranean and Mediterranean-Dietary Approaches to Stop Hypertension Intervention for Neurodegenerative Delay (MIND) Diets and Parkinson's Disease Incidence in Women: Results from the Prospective E3N Cohort.
   Ann Neurol. 2026 Jan 6. doi: 10.1002/ana.78115.
   PubMed         Abstract available
   
   

   
   BMC Neurol

2. CHEN S, Yang N, Liu J, Xu S, et al
   Effect of deep brain stimulation on early-onset Parkinson's disease with mutations in a Han Chinese Mainland population.
   BMC Neurol. 2026 Jan 5. doi: 10.1186/s12883-025-04593.
   PubMed        
   
   
3. ZENG S, Liu H, Han S, Chen J, et al
   The metabolic crossroads: glycolysis in cancer and neurodegeneration.
   BMC Neurol. 2025;26:9.
   PubMed         Abstract available
   
   

   
   BMC Neurosci

4. GHEYBI E, Jalili-Nik M, Hosseinzadeh P, Mirzaei SM, et al
   Evaluation of the neuroprotective effects of alpha lipoic acid-loaded folate-conjugated chitosan nanoparticles against 6-OHDA-induced apoptosis and oxidative stress in an in vitro Parkinson's disease model.
   BMC Neurosci. 2026 Jan 5. doi: 10.1186/s12868-025-00991.
   PubMed        
   
   

   
   Brain Res

5. LI J, You J, Li Z, Zang J, et al
   Identification of the disulfidptosis-related gene IQGAP1 as a potential diagnostic biomarker in Parkinson's disease.
   Brain Res. 2026 Jan 6:150153. doi: 10.1016/j.brainres.2026.150153.
   PubMed         Abstract available
   
   

   
   Exp Neurol

6. TIAN S, Niu M, Qian Q, Zhang K, et al
   Biochanin A exerts neuroprotective effects in Parkinson's disease both in vivo and in vitro by improving mitochondrial dysfunction through the Sirt1 signaling pathway.
   Exp Neurol. 2026;398:115636.
   PubMed         Abstract available
   
   

   
   J Neural Transm (Vienna)

7. D'IORIO A, Di Benedetto GL, Vitale C, Amboni M, et al
   Longitudinal changes in prospective memory in patients with Parkinson's disease.
   J Neural Transm (Vienna). 2026 Jan 6. doi: 10.1007/s00702-025-03100.
   PubMed         Abstract available
   
   
8. FANCIULLI A, Leys F, Hoglinger G, Jost WH, et al
   How to treat cardiovascular autonomic failure in Parkinson's disease.
   J Neural Transm (Vienna). 2026 Jan 3. doi: 10.1007/s00702-025-03096.
   PubMed         Abstract available
   
   
9. SUGAYA K, Kawazoe T, Nakata Y, Okitsu M, et al
   Parkinson's disease subtypes and their relationship to dementia with Lewy bodies: a comparative neuroimaging analysis based on nigrostriatal degeneration.
   J Neural Transm (Vienna). 2026 Jan 3. doi: 10.1007/s00702-025-03097.
   PubMed         Abstract available
   
   

   
   J Neurochem

10. VALDETARO L, Ricciardi MC, Almeida PP, Stockler-Pinto MB, et al
    The Enteric Nervous System as a Mediator of Microbiota-Gut-Brain Interactions in Parkinson's Disease.
    J Neurochem. 2026;170:e70339.
    PubMed         Abstract available
    
    

    
    Mov Disord

11. BURKE R, Schoenfeld MJ, Moll CKE, Gulberti A, et al
    Modulation of Non-Rhythmic Temporal Prediction by Subthalamic Nucleus Deep Brain Stimulation (STN-DBS) in Parkinson's Disease.
    Mov Disord. 2026 Jan 6. doi: 10.1002/mds.70165.
    PubMed         Abstract available
    
    
12. CAO LH, Wan JJ, Yan QQ, Hu Z, et al
    Re-evaluating Dystonia-Linked Gene Variants in a Large European Parkinson's Disease Cohort.
    Mov Disord. 2026 Jan 7. doi: 10.1002/mds.70173.
    PubMed        
    
    
13. LIM AW, Foo JN, Chew EG, Lim SY, et al
    Proteomic and Genetic Insights into Ancestry-Specific Associations in Parkinson's Disease.
    Mov Disord. 2026 Jan 8. doi: 10.1002/mds.70169.
    PubMed         Abstract available
    
    
14. ERFMANN K, Hirschwald J, Hofacker J, Winiker K, et al
    Characteristics of Swallowing Function in People with Parkinson's Disease: A Scoping Review.
    Mov Disord. 2026 Jan 8. doi: 10.1002/mds.70164.
    PubMed         Abstract available
    
    

    
    Neurochem Res

15. HOUSHMAND F, Anjomshoa M, Najafi-Chaleshtori S, Mobini GR, et al
    Targeting Oxidative Stress and Apoptosis with Levothyroxine in Experimental Parkinson's Disease in Rats.
    Neurochem Res. 2026;51:38.
    PubMed        
    
    

    
    Neurology

16. SUN Y, Na HK, Jeon S, Ye BS, et al
    Cerebral Perfusion and Motor Deficits in Drug-Induced Parkinsonism: A Dual-Phase (18)F-FP-CIT PET Study.
    Neurology. 2026;106:e214573.
    PubMed         Abstract available
    
    
17. GERMAN A, Grotemeyer A, Rothhammer V, Doerfler A, et al
    Pearls & Oy-sters: Reversible Leukoencephalopathy and Parkinsonism Due to CNS Involvement in Cryoglobulinemia.
    Neurology. 2026;106:e214622.
    PubMed         Abstract available
    
    
18. THATIKALA A, Boddu AV, Nayar D, Virmani T, et al
    Pearls & Oy-sters: Hereditary Spastic Paraplegia Type 15 Presenting as Juvenile Onset Levodopa-Responsive Parkinsonism.
    Neurology. 2026;106:e214514.
    PubMed         Abstract available
    
    

    
    PLoS One

19. DENG X, Yan X, Song Z, Zheng W, et al
    Genetic analysis of LRRK2 variants in Han Chinese patients with Parkinson's disease.
    PLoS One. 2026;21:e0340448.
    PubMed         Abstract available
    
    
20. ABU-BAIH DH, Elmaidomy AH, Abou-Zied HA, Hussien NA, et al
    Emphasizing the role of oxidative stress and Sirt-1/Nrf2 and TLR-4/NF-kappaB in Tamarix aphylla mediated neuroprotective potential in rotenone-induced Parkinson's disease: In silico and in vivo study.
    PLoS One. 2026;21:e0339010.
    PubMed         Abstract available
    
    
21. LIU W, Xu L, Wang X, Wang J, et al
    Integrative multi-omics and network-based machine learning for early diagnosis of Parkinson's disease.
    PLoS One. 2026;21:e0329980.
    PubMed         Abstract available
    
    
22. WALL C, Sacre A, McMeekin P, Walker R, et al
    Parkinson's disease gait rehabilitation at scale: Insights on personalised smartphone-based music cueing.
    PLoS One. 2026;21:e0340106.
    PubMed         Abstract available
    
    
23. CHENNA S, Joselin A, Theurey P, Bano D, et al
    Integrating simulated and experimental data to identify mitochondrial bioenergetic defects in Parkinson's Disease models.
    PLoS One. 2026;21:e0339326.
    PubMed         Abstract available
    
    

    
    Proc Natl Acad Sci U S A

24. ZHU B, Liu Z, Van R, Wang H, et al
    Highly sensitive chemiluminescence imaging of misfolded proteins in neurodegenerative models.
    Proc Natl Acad Sci U S A. 2026;123:e2513311123.
    PubMed         Abstract available
    
    
25. XU Y, Jin K, Chen J, Li Z, et al
    USP25 inhibition ameliorates Parkinson's disease by restoring mitophagy.
    Proc Natl Acad Sci U S A. 2026;123:e2516471123.
    PubMed         Abstract available
    
    

    
    Rev Neurol

26. LIU J, Gao B, Ma LJ, Gao XB, et al
    Life's Essential 8 and Parkinson's Disease Risk: A Cross-Sectional Study Based on NHANES Data (2005-2018).
    Rev Neurol. 2025;80:38937.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Parkinson's Disease is free of charge.